Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma

CONCLUSION: In patients with inoperable advanced or locally advanced ESCC, peripheral blood PIV, SII, and NLR have predictive value for immunotherapy outcome, SII is an independent risk factor affecting the survival prognosis, and SII ≥834.295 suggests a poor prognosis from immunotherapy.PMID:38362884 | DOI:10.1080/00365521.2024.2319319

Source: Scandinavian Journal of Gastroenterology - February 16, 2024 Category: Gastroenterology Authors: Maodong Fu Zhiyong Li Jun Ma Feng Shen Xiuping Zhang Source Type: research